Zydus Lifesciences has received final approval from the United States Food and Drug Administration USFDA to market Norepinephrine Bitartrate Injection USP4 mg4 mL 1 mgmL Single-Dose Vial USRLD Levophed Norepinephrine Bitartrate is indicated for restoration of blood pressure in adult patients with acute hypotensive state The drug will be manufactured at the groups topical injectable manufacturing facility at Jarod India Norepinephrine Bitartrate Injection USP 1mg1 mL had annual sales of US$ 638 million in the United States according to IQVIA data IQVIA MAT May 2022
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
